A novel mechanism for the regulation of IFN-γ inducible protein-10 expression in rheumatoid arthritis

被引:113
作者
Hanaoka, R
Kasama, T
Muramatsu, M
Yajima, N
Shiozawa, F
Miwa, Y
Negishi, M
Ide, H
Miyaoka, H
Uchida, H
Adachi, M
机构
[1] Showa Univ, Sch Med, Dept Internal Med 1, Div Rheumatol & Clin Immunol,Shinagawa Ku, Tokyo 1428666, Japan
[2] Showa Univ, Sch Med, Dept Orthoped, Tokyo 142, Japan
[3] Furukawabashi Hosp, Dept Orthoped, Tokyo, Japan
关键词
adhesion molecule; fibroblast; IFN-gamma inducible protein-10; rheumatoid arthritis;
D O I
10.1186/ar616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chemokines play an essential role in the progression of rheumatoid arthritis ( RA). In the present study we examined the expression and regulatory mechanisms of IFN-gamma inducible protein (IP)-10 in RA synovitis. RA synovial fluid contained greater amounts of IP-10 than did synovial fluid from patients with osteoarthritis. Immunolocalization analysis indicated that IP-10 was associated mainly with infiltrating macrophage-like cells, and fibroblast-like cells in the RA synovium. The interaction of activated leukocytes with fibroblast-like synoviocytes resulted in marked increases in IP-10 expression and secretion. Moreover, induction of IP-10 was mediated via specific adhesion molecules, as indicated by the finding that both anti-integrin ( CD11b and CD18) and intercellular adhesion molecule-1 antibodies significantly inhibited IP-10 induction. These results suggest that IP-10 expression within inflamed joints appears to be regulated not only by inflammatory cytokines but also by the physical interaction of activated leukocytes with fibroblast-like synoviocytes, and that IP-10 may contribute to the recruitment of specific subpopulations of T cells ( Th1 type) from the bloodstream into the synovial joints.
引用
收藏
页码:R74 / R81
页数:8
相关论文
共 43 条
  • [1] Aarvak T, 1999, SCAND J IMMUNOL, V50, P1
  • [2] HUMAN INTERFERON-INDUCIBLE PROTEIN-10 IS A POTENT INHIBITOR OF ANGIOGENESIS IN-VIVO
    ANGIOLILLO, AL
    SGADARI, C
    TAUB, DD
    LIAO, F
    FARBER, JM
    MAHESHWARI, S
    KLEINMAN, HK
    REAMAN, GH
    TOSATO, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) : 155 - 162
  • [3] Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases
    Arenberg, DA
    Kunkel, SL
    Polverini, PJ
    Morris, SB
    Burdick, MD
    Glass, MC
    Taub, DT
    Iannettoni, MD
    Whyte, TI
    Strieter, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) : 981 - 992
  • [4] Chemokines in autoimmune diseases
    Arimilli, S
    Ferlin, W
    Solvason, N
    Deshpande, S
    Howard, M
    Mocci, S
    [J]. IMMUNOLOGICAL REVIEWS, 2000, 177 : 43 - 51
  • [5] THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS
    ARNETT, FC
    EDWORTHY, SM
    BLOCH, DA
    MCSHANE, DJ
    FRIES, JF
    COOPER, NS
    HEALEY, LA
    KAPLAN, SR
    LIANG, MH
    LUTHRA, HS
    MEDSGER, TA
    MITCHELL, DM
    NEUSTADT, DH
    PINALS, RS
    SCHALLER, JG
    SHARP, JT
    WILDER, RL
    HUNDER, GG
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (03): : 315 - 324
  • [6] CYTOKINE-INDUCED EXPRESSION OF MESSENGER-RNAS FOR CHEMOTACTIC FACTORS IN HUMAN SYNOVIAL-CELLS AND FIBROBLASTS
    BEDARD, PA
    GOLDS, EE
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1993, 154 (02) : 433 - 441
  • [7] Burger D, 1998, ARTHRITIS RHEUM, V41, P1748, DOI 10.1002/1529-0131(199810)41:10<1748::AID-ART7>3.3.CO
  • [8] 2-V
  • [9] Differential Th1/Th2 cytokine patterns in chronic arthritis:: interferon γ is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies
    Cañete, JD
    Martinez, SE
    Farrés, J
    Sanmarti, R
    Blay, M
    Gómez, A
    Salvador, G
    Muñoz-Gómez, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (04) : 263 - 268
  • [10] Mechanisms of disease: Cytokine pathways and joint inflammation in rheumatoid arthritis.
    Choy, EHS
    Panayi, GS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (12) : 907 - 916